Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
17
NEPH Quote, Financials, Valuation and Earnings
Last price:
$2.87
Seasonality move
:
28.43%
Day range:
$2.86 - $3.00
52-week range:
$1.64 - $6.42
Dividend yield:
0%
P/E ratio:
25.18x
P/S ratio:
1.62x
P/B ratio:
2.90x
Volume:
7.8K
Avg. volume:
43.1K
1-year change:
41.38%
Market cap:
$29.6M
Revenue:
$18.8M
EPS (TTM):
$0.11
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nephros, Inc. has 143.9% upside to fair value with a price target of $7.00 per share.
NEPH vs. S&P 500
-
Over the past 5 trading days, Nephros, Inc. has underperformed the S&P 500 by -5.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nephros, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nephros, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Nephros, Inc. reported revenues of $4.7M.
Earnings Growth
-
Nephros, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Nephros, Inc. reported earnings per share of $0.01.
Enterprise value:
26.2M
EV / Invested capital:
--
Price / LTM sales:
1.62x
EV / EBIT:
22.87x
EV / Revenue:
1.40x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
15.93x
Price / Operating cash flow:
18.47x
Enterprise value / EBITDA:
20.37x
Gross Profit (TTM):
$11.5M
Return On Assets:
9.61%
Net Income Margin (TTM):
6.36%
Return On Equity:
12.52%
Return On Invested Capital:
11.08%
Operating Margin:
0.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $14.2M | $14.2M | $18.8M | $3.9M | $4.7M | |
| Gross Profit | $8.2M | $8.6M | $11.5M | $2.4M | $2.7M | |
| Operating Income | -$1.6M | $6K | $1.1M | $317K | $18K | |
| EBITDA | -$1.1M | $143K | $1.3M | $353K | $50K | |
| Diluted EPS | -$0.15 | $0.01 | $0.11 | $0.03 | $0.01 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $13.6M | $8.3M | $8.4M | $8.3M | $11.2M | |
| Total Assets | $17.7M | $11M | $11.9M | $11.2M | $13.6M | |
| Current Liabilities | $2.4M | $1.4M | $2.1M | $1.6M | $2.8M | |
| Total Liabilities | $2.9M | $2.1M | $3.5M | $2.6M | $3.4M | |
| Total Equity | $14.7M | $8.9M | $8.4M | $8.6M | $10.2M | |
| Total Debt | $687K | $777K | $1.4M | $1.1M | $672K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $827K | -$492K | $1.6M | $1.3M | $230K | |
| Cash From Investing | -$75K | -$50K | -- | -- | -- | |
| Cash From Financing | -$79K | -$5K | -$5K | -$1K | -$1K | |
| Free Cash Flow | $752K | -$547K | $1.6M | $1.3M | $230K | |
NEPH
Sector
Market Cap
$29.6M
$463.6M
Price % of 52-Week High
44.7%
75.3%
Dividend Yield
0%
0%
Shareholder Yield
0.17%
1.64%
1-Year Price Total Return
41.38%
--
Beta (5-Year)
1.558
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.94
200-day SMA
Sell
Level
$4.32
Bollinger Bands (100)
Sell
Level
3.59 - 5.09
Chaikin Money Flow
Sell
Level
-997
20-day SMA
Sell
Level
$3.23
Relative Strength Index (RSI14)
Sell
Level
35.20
ADX Line
Sell
Level
14.7
Williams %R
Buy
Level
-81.1474
50-day SMA
Sell
Level
$3.75
MACD (12, 26)
Buy
Level
0.76
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-96K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.2293)
Buy
CA Score
(Annual)
Level (1.7203)
Buy
Beneish M-Score
(Annual)
Level (-2.4539)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.3937)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Stock Forecast FAQ
In the current month, NEPH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NEPH average analyst price target in the past 3 months is $7.00.
-
Where Will Nephros, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nephros, Inc. share price will rise to $7.00 per share over the next 12 months.
-
What Do Analysts Say About Nephros, Inc.?
Analysts are divided on their view about Nephros, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nephros, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Nephros, Inc.'s Price Target?
The price target for Nephros, Inc. over the next 1-year time period is forecast to be $7.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NEPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nephros, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NEPH?
You can purchase shares of Nephros, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nephros, Inc. shares.
-
What Is The Nephros, Inc. Share Price Today?
Nephros, Inc. was last trading at $2.87 per share. This represents the most recent stock quote for Nephros, Inc.. Yesterday, Nephros, Inc. closed at $2.87 per share.
-
How To Buy Nephros, Inc. Stock Online?
In order to purchase Nephros, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NEPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NEPH
Sector
P/E ratio
25.18x
19.72x
PEG ratio
0.02x
0.18x
P/B ratio
2.90x
1.73x
Price / LTM sales
1.62x
0.85x
Growth Metrics
NEPH
Sector
Revenue growth
22.2%
4.72%
Earnings growth
-83.38%
1.57%
Revenue (5-year growth)
17.02%
5.93%
Earnings forecast
$0.01
$0.28
Profitability
NEPH
Sector
Profitability FY 2025
$11.5M
$236M
Return on invested capital
11.08%
4.52%
Return on assets
9.61%
3.07%
Return on equity
12.52%
7.95%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
May
7
Estimated Next Earnings Date
Feb
5
Balance Sheet
NEPH
Sector
Total cash
$5.4M
$138.8M
Short term investments
--
$30.7M
Total assets
$13.6M
$1.4B
Long term debt
$672K
$35.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
